Dr Phillip Schwartz
Dr. Phillip Schwartz is Refana’s Chief Science Officer. Born in Chicago, Dr. Schwartz studied and taught at Rockefeller University under a Nobel Laureate Mentor, at the Weizmann Institute of Science, at the Harvard Medical School, where he earned his PhD in Medicine, and the Dana Farber Cancer Institute. He is the Founder and currently the President of EnteraBio, a NASDAQ-listed biotech company based in Israel. He brings 30+ years of biotech, pharmaceutical industry experience, including stints with Merck-Serono and Endo Pharmaceuticals.